Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer

Clinical trial NCT00498225 · COMPLETED

Trial details

NCT number: NCT00498225
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2007-07-01
Primary completion: 2011-07-01
Enrollment: 834

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.